title: The origin of circulating CD36 in type 2 diabetes.
abstract: OBJECTIVE
  Elevated plasma levels of the fatty acid transporter, CD36, have been shown to constitute a novel biomarker for type 2 diabetes mellitus (T2DM). We recently reported such circulating CD36 to be entirely associated with cellular microparticles (MPs) and aim here to determine the absolute levels and cellular origin(s) of these CD36+MPs in persons with T2DM.
  
  
  METHODS
  An ex vivo case-control study was conducted using plasma samples from 33 obese individuals with T2DM (body mass index (BMI)=39.9±6.4 kg m(-2); age=57±9 years; 18 male:15 female) and age- and gender-matched lean and obese non-T2DM controls (BMI=23.6±1.8 kg m(-2) and 33.5±5.9 kg m(-2), respectively). Flow cytometry was used to analyse surface expression of CD36 together with tissue-specific markers: CD41, CD235a, CD14, CD105 and phosphatidyl serine on plasma MPs. An enzyme-linked immunosorbent assay was used to quantify absolute CD36 protein concentrations.
  
  
  RESULTS
  CD36+MP levels were significantly higher in obese people with T2DM (P<0.00001) and were primarily derived from erythrocytes (CD235a+=35.8±14.6%); although this did not correlate with haemoglobin A(1c). By contrast, the main source of CD36+MPs in non-T2DM individuals was endothelial cells (CD105+=40.9±8.3% and 33.9±8.3% for lean and obese controls, respectively). Across the entire cohort, plasma CD36 protein concentration varied from undetectable to 22.9 μg ml(-1) and was positively correlated with CD36+MPs measured by flow cytometry (P=0.0006) but only weakly associated with the distribution of controls and T2DM (P=0.021). Multivariate analysis confirmed that plasma CD36+MP levels were a much better biomarker for diabetes than CD36 protein concentration (P=0.009 vs P=0.398, respectively).
  
  
  CONCLUSIONS
  Both the levels and cellular profile of CD36+MPs differ in T2DM compared with controls, suggesting that these specific vesicles could represent distinct biological vectors contributing to the pathology of the disease.
authors: 1] Cancer Research Unit, School of Biomedical Sciences and Pharmacy, Faculty of Health, the University of Newcastle, Newcastle, NSW, Australia [2] Hunter Medical Research Institute, New Lambton, NSW, Australia.
authors: M J
authors: MJ
authors: Alkhatatbeh
authors: A K
authors: AK
authors: Enjeti
authors: S
authors: S
authors: Acharya
authors: R F
authors: RF
authors: Thorne
authors: L F
authors: LF
authors: Lincz
references: Blood. 2011 Jun 9;117(23):6355-66
references: 21478428
references: Biochem Biophys Res Commun. 1997 Nov 26;240(3):812-8
references: 9398651
references: Thromb Res. 2012 Jan;129(1):95-7
references: 22035651
references: Nutr Metab Cardiovasc Dis. 2011 Sep;21(9):665-71
references: 20399083
references: Thromb Haemost. 2011 Aug;106(2):310-21
references: 21713319
references: J Nutr Biochem. 2006 Nov;17(11):760-5
references: 16517147
references: Circulation. 2006 Sep 12;114(11):1169-76
references: 16952981
references: J Nutr Biochem. 2009 Jun;20(6):477-84
references: 18789673
references: Am J Pathol. 2008 Oct;173(4):1210-9
references: 18772329
references: J Thromb Haemost. 2011 Apr;9(4):844-51
references: 21276198
references: Nat Med. 2001 Jul;7(7):840-6
references: 11433350
references: Diabetes. 2002 Sep;51(9):2840-5
references: 12196479
references: J Atheroscler Thromb. 2010 Jun 30;17(6):539-45
references: 20134099
references: Semin Thromb Hemost. 2008 Oct;34(7):683-91
references: 19085769
references: Diabetes Metab. 2008 Feb;34 Suppl 1:S27-32
references: 18358424
references: Diabet Med. 2005 Dec;22(12):1657-62
references: 16401308
references: Diabetes Care. 2008 Feb;31(2):328-34
references: 18000176
references: Horm Metab Res. 2011 Oct;43(11):760-5
references: 22009370
references: Obes Surg. 2006 Mar;16(3):251-7
references: 16545154
references: Blood. 1982 Oct;60(4):834-40
references: 7115953
references: Obes Res. 1995 Nov;3(6):563-71
references: 8653533
references: Eur J Haematol. 1997 Apr;58(4):246-50
references: 9186535
references: Semin Thromb Hemost. 2010 Nov;36(8):845-56
references: 21049385
references: FEBS Lett. 2007 Mar 20;581(6):1227-32
references: 17346709
references: J Thromb Haemost. 2009 Jan;7(1):190-7
references: 18983485
references: Mediators Inflamm. 2010;2010:250476
references: 20634911
references: Thromb Haemost. 2009 Mar;101(3):439-51
references: 19277403
references: Br J Haematol. 2008 May;141(4):549-56
references: 18419623
references: PLoS Med. 2005 Feb;2(2):e45
references: 15737001
references: J Clin Endocrinol Metab. 2010 Apr;95(4):1939-46
references: 20139232
references: Diabetes Metab. 2006 Feb;32(1):82-5
references: 16523191
references: Circ Res. 2010 Oct 29;107(9):1047-57
references: 21030722
references: Diabetologia. 2002 Apr;45(4):550-5
references: 12032632
references: J Thromb Haemost. 2010 Nov;8(11):2571-4
references: 20831623
references: Crit Rev Oncol Hematol. 1999 Apr;30(2):111-42
references: 10439058
references: Clin Chim Acta. 2010 Dec 14;411(23-24):2079-82
references: 20837002
references: J Proteomics. 2010 Jan 3;73(3):396-402
references: 19660581
references: Cleve Clin J Med. 2009 Apr;76 Suppl 2:S27-30
references: 19376978
references: Circulation. 2000 Feb 29;101(8):841-3
references: 10694520
references: Circulation. 2002 Nov 5;106(19):2442-7
references: 12417540
references: Stroke. 2008 Nov;39(11):3092-5
references: 18723424
references: Cerebrovasc Dis. 2011;31(5):485-93
references: 21411989
references: Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1926
references: 16857960
references: Hum Mol Genet. 2011 Jan 1;20(1):193-201
references: 20935172
references: J Clin Invest. 2001 Sep;108(6):785-91
references: 11560944
references: Thromb Res. 2010 Apr;125(4):332-9
references: 20117824
references: Biochem Biophys Res Commun. 2000 Aug 28;275(2):446-54
references: 10964685
references: J Intern Med. 2012 Mar;271(3):294-304
references: 21883535
references: Leukemia. 2006 Sep;20(9):1487-95
references: 16791265
references: Am J Obstet Gynecol. 2004 Oct;191(4):1418-24
references: 15507976